Differences in Uptravi maintenance doses had no impact on the risk of hospitalization among adults with PAH, a claims ...

Investigators say more research is warranted to optimize management of patients with pulmonary arterial hypertension (PAH) ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other best ...

Discover Insmed Inc.'s groundbreaking patent for treating Mycobacterium avium complex lung infections with a novel aerosolized amikacin method, promising improved outcomes.

In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...